Alpha DNA Investment Management’s TopBuild BLD Stock Holding History

Alpha DNA Investment Management’s Portfolio BLD Stock Details BLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,458	Closed	-$562K	–	207
2024 Q2	$562K	Buy	1,458 +300	+26%	+$122K	0.22%	89
2024 Q1	$510K	Sell	1,158 -1,394	-55%	-$545K	0.19%	144
2023 Q4	$955K	Sell	2,552 -139	-5%	-$39.8K	0.37%	49
2023 Q3	$677K	Buy	2,691 +1,866	+226%	+$514K	0.28%	78
2023 Q2	$219K	Buy	+825	New	+$181K	0.07%	142
2021 Q1	–	Sell	-7	Closed	-$1K	–	688
2020 Q4	$1K	Buy	+7	New	+$1.24K	﹤0.01%	510

Other funds holding BLD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alpha DNA Investment Management's BLD Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of TopBuild (BLD) in Q3 2024, closing a stake of 1,458 shares — an estimated $562K sold.

Alpha DNA Investment Management first reported a position in BLD in Q4 2020 and held it in 6 quarters. The position peaked at $955K in Q4 2023. 524 funds tracked by Wall St. Rank hold BLD as of Q3 2024.

Alpha DNA Investment Management reported no remaining TopBuild position as of Q3 2024 after selling out during the quarter.
Alpha DNA Investment Management sold 1,458 TopBuild shares in Q3 2024, an estimated $562K.
Alpha DNA Investment Management first reported a position in TopBuild in Q4 2020 and held it in 6 quarters.
Alpha DNA Investment Management's TopBuild position peaked at $955K in Q4 2023.
524 funds tracked by Wall St. Rank held TopBuild as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.